Eurand, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in developing innovative drug delivery systems, particularly in the areas of oral and injectable formulations. With a focus on enhancing bioavailability and patient compliance, Eurand's core products include advanced formulations that utilise proprietary technologies, setting them apart in a competitive market. The company operates primarily in North America and Europe, catering to a diverse clientele that includes major pharmaceutical firms. Notable achievements include successful partnerships and collaborations that have expanded its market reach and product offerings. Eurand, Inc. continues to be recognised for its commitment to quality and innovation, solidifying its position as a trusted name in the pharmaceutical landscape.
How does Eurand, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eurand, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eurand, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Eurand may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company appears to be operating without a defined strategy for addressing carbon emissions or contributing to climate action within its industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eurand, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
